23andMe's share price keeps on falling in the wake of hacks and losses

• 23andMe stock is down over 95% from its peak, cutting its value from $6 billion to $345 million.
• The genetic-testing company is facing financial and strategic challenges, and was hacked last year.
• The startup's backers, including Sequoia Capital, have taken big hits to their investments.

23andMe has gone from a Silicon Valley darling and pop-culture sensation to being shunned by investors and threatened with delisting.

The genetic-testing startup made its stock market debut in the summer of 2021 to great fanfare, and was once worth as much as $6 billion.

However, its shares have since nosedived more than 95%, leaving it valued at about $345 million.

The shares were trading at just 72 cents on Thursday, the Nasdaq exchange warned in November the company could be delisted if they remained below $1 for too long.